CVS - CVS Health Corporation

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Total revenue
243,991,000
194,579,000
184,765,000
177,526,000
153,290,000
Cost of revenue
200,809,000
163,041,000
156,220,000
148,669,000
126,762,000
Gross profit
43,182,000
31,538,000
28,545,000
28,857,000
26,528,000
Operating expenses
Research development
-
-
-
-
-
Selling general and administrative
-
-
-
18,519,000
17,074,000
Total operating expenses
31,500,000
21,368,000
19,028,000
18,519,000
17,074,000
Operating income or loss
11,682,000
10,170,000
9,517,000
10,338,000
9,454,000
Interest expense
3,034,000
2,619,000
1,062,000
1,078,000
859,000
Total other income/expenses net
-1,883,000
-6,145,000
-208,000
-643,000
0
Income before tax
6,765,000
1,406,000
8,268,000
8,637,000
8,616,000
Income tax expense
2,300,000
2,002,000
1,637,000
3,317,000
3,386,000
Income from continuing operations
4,465,000
-596,000
6,631,000
5,320,000
5,230,000
Net income
4,468,000
-594,000
6,622,000
5,317,000
5,237,000
Net income available to common shareholders
4,468,000
-594,000
6,622,000
5,317,000
5,237,000
Reported EPS
Basic
-
-0.57
6.47
4.93
4.66
Diluted
-
-0.57
6.44
4.90
4.63
Weighted average shares outstanding
Basic
-
1,044,000
1,020,000
1,073,000
1,118,000
Diluted
-
1,044,000
1,024,000
1,079,000
1,126,000
EBITDA
-
6,743,000
11,809,000
12,190,000
11,567,000